Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.81 is in line with its 5-year average of 0.74, near the low end of its 5-year range (0.61–1.29).
As of the fiscal period ended Friday, July 31, 2026. 3.65% below its 12-month average of 0.84.
Reported quarterly quick ratio; no daily interpolation. Q3 FY2026 (2026-07-31): 0.81.
QUICK RATIO (ACID-TEST)
0.81
QUICK RATIO (ACID-TEST) AVG TTM
0.84
QUICK RATIO (ACID-TEST) AVG 3Y
0.78
QUICK RATIO (ACID-TEST) AVG 5Y
0.74
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.65%
CURRENT VS 3Y AVG
+3.49%
CURRENT VS 5Y AVG
+8.69%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
-74.76%
vs the sector median at left
High Tide Inc.
Market Cap
$236.81M
Quick Ratio (Acid-Test)
0.81
TTM Avg
0.84
3Y Avg
0.78
5Y Avg
0.74
Market Cap
$235.18M
Quick Ratio (Acid-Test)
2.96
TTM Avg
4.42
3Y Avg
4.46
5Y Avg
4.62
Market Cap
$234.56M
Quick Ratio (Acid-Test)
17.19
TTM Avg
13.55
3Y Avg
8.08
5Y Avg
8.08
Market Cap
$241.59M
Quick Ratio (Acid-Test)
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.59
Market Cap
$239.98M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.13
3Y Avg
1.14
5Y Avg
1.18
Market Cap
$229.96M
Quick Ratio (Acid-Test)
2.85
TTM Avg
2.31
3Y Avg
2.01
5Y Avg
2.00
Market Cap
$242.52M
Quick Ratio (Acid-Test)
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$242.35M
Quick Ratio (Acid-Test)
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $236.81M | 0.81 | 0.84 | 0.78 | 0.74 |
| MacroGenics, Inc. (MGNX)vs › | $235.18M | 2.96 | 4.42 | 4.46 | 4.62 |
| BioAge Labs Inc. (BIOA)vs › | $234.56M | 17.19 | 13.55 | 8.08 | 8.08 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $241.59M | 4.70 | 7.13 | 7.51 | 5.59 |
| InflaRx N.V. (IFRX)vs › | $239.19M | 8.22 | 4.35 | 5.50 | 5.94 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.98M | 1.35 | 1.13 | 1.14 | 1.18 |
| Biodesix, Inc. (BDSX)vs › | $229.96M | 2.85 | 2.31 | 2.01 | 2.00 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.52M | 1.54 | 1.17 | 19.33 | 29.22 |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | 0.10 | 1.46 | 1.56 | 2.73 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.71M | 2.69 | 2.01 | 1.61 | 1.29 |
Quick Ratio
0.81
Excludes inventory
Current Ratio
1.50
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-31 | 0.81 |
| 2026-04-30 | 0.66 |
| 2026-01-31 | 0.72 |
| 2025-10-31 | 0.70 |
| 2025-07-31 | 1.29 |
| 2025-04-30 | 0.97 |
| 2025-01-31 | 0.95 |
| 2024-10-31 | 0.92 |
| 2024-07-31 | 0.78 |
| 2024-04-30 | 0.72 |
| 2024-01-31 | 0.69 |
| 2023-12-29 | 0.73 |
| 2023-07-31 | 0.70 |
| 2023-04-30 | 0.61 |
| 2023-01-31 | 0.64 |
| 2022-10-31 | 0.68 |
| 2022-07-31 | 0.78 |
| 2022-04-30 | 0.69 |
| 2022-01-31 | 0.62 |
| 2021-10-31 | 0.72 |
| 2021-07-31 | 1.18 |
| 2021-04-30 | 1.03 |
| 2021-01-31 | 0.57 |
| 2020-10-31 | 0.49 |
| 2020-07-31 | 0.45 |
| 2020-04-30 | 0.31 |
| 2020-01-31 | 0.35 |
| 2019-10-31 | 0.56 |
| 2019-07-31 | 3.95 |
| 2019-04-30 | 3.36 |
| 2019-01-31 | 3.72 |
| 2018-10-31 | 5.42 |
| 2018-07-31 | 2.72 |
| 2018-04-30 | 0.00 |
| 2018-01-31 | 0.00 |
| 2017-10-31 | 0.33 |
| 2017-07-31 | 0.00 |
